xylitol has been researched along with daptomycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLaren, AC; McLaren, SG; Smeltzer, M | 1 |
| Evans, RP; Haggard, WO; McLaren, SG; Smeltzer, MS; Weiss, BD; Weiss, EC | 1 |
| Beenken, KE; Bellamy, W; Bradney, L; Gruenwald, MJ; Haggard, WO; McLaren, SG; Skinner, RA; Smeltzer, MS; Smith, JK; Spencer, HJ | 1 |
| Courtney, HS; Haggard, WO; Lewis, G; Parker, AC; Salehi, A | 1 |
4 other study(ies) available for xylitol and daptomycin
| Article | Year |
|---|---|
Xylitol and glycine fillers increase permeability of PMMA to enhance elution of daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Carriers; Glycine; Microspheres; Permeability; Polymethyl Methacrylate; Xylitol | 2006 |
Optimized elution of daptomycin from polymethylmethacrylate beads.
Topics: Bone Cements; Chemistry, Pharmaceutical; Daptomycin; Drug Carriers; Gentamicins; Polymethyl Methacrylate; Vancomycin; Xylitol | 2009 |
Use of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Chronic Disease; Daptomycin; Debridement; Delayed-Action Preparations; Disease Models, Animal; Humans; Male; Osteomyelitis; Polymethyl Methacrylate; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Xylitol | 2012 |
A daptomycin-xylitol-loaded polymethylmethacrylate bone cement: how much xylitol should be used?
Topics: Anti-Bacterial Agents; Bone Cements; Daptomycin; Drug Carriers; Humans; Xylitol | 2013 |